United States: GOVERNMENT RESOURCE ACCOUNTABILITY DURING THE COVID-19 PANDEMIC
A report from the United States prepared as Part of a Global and Country-Level Analysis in 18 Countries.
Topics: Access to medicines, Community monitoring, COVID-19
Resource Topic: Access to medicines
-
-
“We were ready to live or DIE fighting for the cause of our community”
Inside the 42-day non-stop sit-in protest over HIV drugs in India.
Topics: Access to medicines
-
Analysis of ARV Procurement in the Russian Federation in 2021
This publication aims to contribute to the efforts undertaken in the fight against the HIV epidemic in Russia.
Topics: Access to medicines
-
Mapping COVID-19 Access Gaps: Results from 14 Countries & Territories
Assessing progress on access to COVID-19 tools across 14 countries: Bangladesh, Democratic Republic of the Congo, Haiti, Jamaica, Liberia, Madagascar, Nepal, Nigeria, Perú, Senegal, Somalia (and de facto state Somaliland), Uganda and Ukraine.
Topics: Access to medicines, COVID-19
-
-
-
Use of modern social media to improve tracking and addressing stock-outs by community-based organisations
As featured at #AIDS2022.
Topics: Access to medicines, Community monitoring
-
-
ITPC Global Annual Review 2021 – Standing Firm
This report highlights the last year of work under our 2021-2023 Strategic Plan. It summarizes our successes, challenges, and operational capacity in 2021, and shows what investing in communities can do.
Topics: Access to medicines, Community monitoring, COVID-19
-
POSTER: Assessing the impacts of Covid-19 on people living with HIV in Uganda
COVID-19 amplified crises across health, human rights and socio-economic domains worsening conditions for PLHIV in Uganda.
Topics: Access to medicines, Community monitoring, COVID-19
-
POSTER: The effects of Covid-19 on HIV & TB services in China, Guatemala, India, Nepal & Sierra Leone
COVID-19 devastated some HIV and TB services while galvanizing others.
Topics: Access to medicines, Community monitoring, COVID-19
-
Ending Cryptococcal Meningitis Deaths by 2030: A New Global Initiative
This Strategic Framework outlines the key reasons why a global strategy to address CM deaths is needed and what essential programmatic elements are required to make this a reality.
Topics: Access to medicines
